194 related articles for article (PubMed ID: 6110451)
21. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.
Lanza F; Cazenave JP; Beretz A; Sutter-Bay A; Kretz JG; Kieny R
Agents Actions; 1986 Aug; 18(5-6):586-95. PubMed ID: 3020942
[TBL] [Abstract][Full Text] [Related]
22. Effects of alpha-adrenoceptor antagonists administered intraventricularly on central hypotensive action of clonidine and on central hypertensive action of methoxamine in rabbits.
Kim YI; Paik YH; Kang SS; Kim JH
Arch Int Pharmacodyn Ther; 1982 May; 257(1):66-76. PubMed ID: 6126161
[TBL] [Abstract][Full Text] [Related]
23. Effects of imidazoline and non-imidazoline alpha-adrenergic agents on canine platelet aggregation.
Hikasa Y; Abe M; Satoh T; Hisashi Y; Ogasawara S; Matsuda H
Pharmacology; 1999 Apr; 58(4):171-82. PubMed ID: 10077736
[TBL] [Abstract][Full Text] [Related]
24. Potentiation by yohimbine of alpha-adrenoceptor-mediated vasoconstriction in response to clonidine in the rabbit ear vein.
Zhao D; Ren LM; Lu HG; Zhang X
Eur J Pharmacol; 2008 Jul; 589(1-3):201-5. PubMed ID: 18534573
[TBL] [Abstract][Full Text] [Related]
25. Platelet beta-adrenoceptors.
Kerry R; Scrutton MC
Br J Pharmacol; 1983 Jul; 79(3):681-91. PubMed ID: 6140045
[TBL] [Abstract][Full Text] [Related]
26. Effects of imidazoline and nonimidazoline α-adrenoceptor agonists and antagonists, including xylazine, medetomidine, dexmedetomidine, yohimbine, and atipamezole, on aggregation of feline platelets.
Matsukawa T; Hikasa Y
Am J Vet Res; 2020 Feb; 81(2):159-171. PubMed ID: 31985287
[TBL] [Abstract][Full Text] [Related]
27. The effects of alpha adrenergic agents on human platelet aggregation.
Hsu CY; Knapp DR; Halushka PV
J Pharmacol Exp Ther; 1979 Mar; 208(3):366-70. PubMed ID: 34707
[TBL] [Abstract][Full Text] [Related]
28. Central alpha-adrenoceptor subtypes involved in the emetic pathway in cats.
Hikasa Y; Akiba T; Iino Y; Matsukura M; Takase K; Ogasawara S
Eur J Pharmacol; 1992 Dec; 229(2-3):241-51. PubMed ID: 1362706
[TBL] [Abstract][Full Text] [Related]
29. Blood platelet adrenoceptor: aggregatory and antiaggregatory activity of imidazoline drugs.
Petrusewicz J; Kaliszan R
Pharmacology; 1986; 33(5):249-55. PubMed ID: 3797465
[TBL] [Abstract][Full Text] [Related]
30. The role of alpha- and beta-adrenoceptor subtypes in mediating the effects of catecholamines on fasting glucose and insulin concentrations in the rat.
John GW; Doxey JC; Walter DS; Reid JL
Br J Pharmacol; 1990 Aug; 100(4):699-704. PubMed ID: 1976400
[TBL] [Abstract][Full Text] [Related]
31. Characterization of dog platelet alpha-adrenergic receptor: lack of in vivo down regulation by adrenergic agonist treatments.
Villeneuve A; Berlan M; Lafontan M; Montastruc JL
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 81(1):181-7. PubMed ID: 2861047
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide.
Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
Br J Pharmacol; 1990 Mar; 99(3):481-6. PubMed ID: 1970497
[TBL] [Abstract][Full Text] [Related]
33. Characterization of postsynaptic alpha-adrenoceptors in the isolated rat tail artery.
Savino EA; Varela A
Arch Int Pharmacodyn Ther; 1991; 309():137-46. PubMed ID: 1679620
[TBL] [Abstract][Full Text] [Related]
34. Characterization of alpha1-adrenoceptor subtypes mediating vasoconstriction in human umbilical vein.
Errasti AE; Velo MP; Torres RM; Sardi SP; Rothlin RP
Br J Pharmacol; 1999 Jan; 126(2):437-42. PubMed ID: 10077236
[TBL] [Abstract][Full Text] [Related]
35. Synergistic responses in human platelets. Comparison between aggregation, secretion and cytosolic Ca2+ concentration.
Thompson NT; Scrutton MC; Wallis RB
Eur J Biochem; 1986 Dec; 161(2):399-408. PubMed ID: 3490977
[TBL] [Abstract][Full Text] [Related]
36. Adrenoceptor-activation of oxygen consumption in rat parotid acini.
Glenert U; Nauntofte B
Pharmacol Toxicol; 1990 Apr; 66(4):266-72. PubMed ID: 1973537
[TBL] [Abstract][Full Text] [Related]
37. Alpha adrenoceptor subtypes involved in the emetic action in dogs.
Hikasa Y; Ogasawara S; Takase K
J Pharmacol Exp Ther; 1992 May; 261(2):746-54. PubMed ID: 1349647
[TBL] [Abstract][Full Text] [Related]
38. Adrenoceptor profile of blood vessels in the knee joint of the rabbit.
Ferrell WR; Khoshbaten A
J Physiol; 1989 Jul; 414():377-83. PubMed ID: 2575163
[TBL] [Abstract][Full Text] [Related]
39. Alpha 2-adrenoceptor in HT29 human colon adenocarcinoma cell-line: study of [3H](-)-adrenaline binding.
Sénard JM; Mauriège P; Daviaud D; Paris H
Eur J Pharmacol; 1989 Mar; 162(2):225-36. PubMed ID: 2566497
[TBL] [Abstract][Full Text] [Related]
40. Critical assessment of the platelet adenylate cyclase system as a potential model for testing alpha 2 adrenergic activity.
Ferry N; Henry D; Battais E; Mary A; Bonne C; Hanoune J
Biochem Pharmacol; 1986 May; 35(9):1511-6. PubMed ID: 2871841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
